[25 April 2013]
Products Affected - Description
Glycopyrrolate 0.2 mg/mL injection, American Regent
1 mL vial (NDC 00517-4601-25)
2 mL vial (NDC 00517-4602-25)
5 mL vial (NDC 00517-4605-25)
20 mL vial (NDC 00517-4620-25)
Glycopyrrolate 0.2 mg/mL injection, West-Ward
20 mL vial (NDC 00641-6036-10)
Robinul 0.2 mg/mL injection, West-Ward
1 mL vial (NDC 00641-6104-25)
20 mL vial (NDC 00641-6107-10)
Reason for the Shortage
- West-Ward has acquired all Baxter Robinul and generic glycopyrrolate injection products. West-Ward cannot provide a reason for the shortage.
- American Regent had temporarily suspended manufacture of most drug products in April, 2011.
- American Regent resumed manufacturing in Shirley, New York in early-May, 2011.
Available Products
Glycopyrrolate 0.2 mg/mL injection, West-Ward
1 mL vial (NDC 00641-6033-25)
2 mL vial (NDC 00641-6034-25)
5 mL vial (NDC 00641-6035-25)
Robinul 0.2 mg/mL injection, West-Ward
2 mL vial (NDC 00641-6105-25)
5 mL vial (NDC 00641-6106-25)
Estimated Resupply Dates
- American Regent has all glycopyrrolate presentations on back order and the company cannot estimate a release date.
- West-Ward has Robinul 0.2 mg/mL 1 mL and 20 mL vials on back order and the company cannot estimate a release date. Glycopyrrolate 0.2 mg/mL 20 mL vials are on back order and the company cannot estimate a release date.
Related Shortages
Updated
April 25, 2013; April 17, 2013; April 1, 2013; March 27, 2013; February 27, 2013; January 23, 2013; December 17, 2012; December 12, 2012; November 16, 2012; November 9, 2012; October 26, 2012; September 26, 2012; August 13, 2012; June 29, 2012; April 27, 2012; April 3, 2012; February 29, 2012; February 7, 2012; January 31, 2012; January 24, 2012; January 11, 2012; December 14, 2011; November 30, 2011; November 22, 2011; November 3, 2011; September 16, 2011; August 23, 2011; July 22, 2011; July 18, 2011; June 9, 2011; May 6, 2011; April 29, 2011; April 13, 2011; March 18, 2011; March 9, 2011; February 7, 2011, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins